Repligen
RGEN
#1928
Rank
$10.36 B
Marketcap
$162.18
Share price
-0.37%
Change (1 day)
8.85%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2026 (TTM): -$0.20

According to Repligen 's latest financial reports the company's current EPS (TTM) is -$0.20. In 2025 the company made an earnings per share (EPS) of $0.87 an increase over its 2024 EPS that were of -$0.51.

EPS history for Repligen from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$0.20-122.99%
2025$0.87-270.59%
2024-$0.51-168%
2023$0.75-77.68%
2022$3.3643.59%
2021$2.34105.26%
2020$1.14153.33%
2019$0.4518.42%
2018$0.38-47.95%
2017$0.73108.57%
2016$0.3520.69%
2015$0.2916%
2014$0.25-48.98%
2013$0.496.52%
2012$0.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$0.71-455.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$18.99-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$8.73-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$4.52-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-$0.38 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-$1.52 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$6.97-3,585.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$1.17-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-$0.09000-55.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
$1.02-610.00%๐Ÿ‡บ๐Ÿ‡ธ USA